HCW Biologics Inc. Quarterly Return On Assets in % from Q1 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
HCW Biologics Inc. quarterly/annual Return On Assets history and growth rate from Q1 2022 to Q3 2024.
  • HCW Biologics Inc. Return On Assets for the quarter ending September 30, 2024 was -133 %, a 179% decline year-over-year.
  • HCW Biologics Inc. annual Return On Assets for 2023 was -67.9 %, a 124% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -133 -85.2 -179% Jul 1, 2024 Sep 30, 2024
Q2 2024 -126 -85.1 -206% Apr 1, 2024 Jun 30, 2024
Q1 2024 -81.7 -43.9 -116% Jan 1, 2024 Mar 31, 2024
Q4 2023 -67.9 -37.6 -124% Oct 1, 2023 Dec 31, 2023
Q3 2023 -47.7 -22.8 -91.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 -41.3 -16.7 -67.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -37.9 -10.1 -36.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -30.3 Oct 1, 2022 Dec 31, 2022
Q3 2022 -24.9 Jul 1, 2022 Sep 30, 2022
Q2 2022 -24.7 Apr 1, 2022 Jun 30, 2022
Q1 2022 -27.8 Jan 1, 2022 Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.